Takeda et al. identified a ROCK-survivin anti-apoptotic axis in pancreatic cancer stem cells and that inhibiting ROCK resulted in decreased survivin expression, leading to the sensitization of cells to gemcitabine[20]. The gene discussed is BIRC5; the disease is pancreatic neoplasm.